首页 | 本学科首页   官方微博 | 高级检索  
     

小细胞肺癌Notch-1表达相关性及预后分析
引用本文:肖维华,马海芬,李君强,虞继红,贺吉,陈国荣. 小细胞肺癌Notch-1表达相关性及预后分析[J]. 中国综合临床, 2011, 27(10). DOI: 10.3760/cma.j.issn.1008-6315.2011.10.033
作者姓名:肖维华  马海芬  李君强  虞继红  贺吉  陈国荣
作者单位:1. 325000,温州医学院附属第一医院病理科
2. 宁波市北仑区人民医院病理科
摘    要:目的 研究Notch-1抗体在小细胞肺癌(SCLC)及非小细胞肺癌(NSCLC)中表达的临床意义,并分析其对预后的影响.方法 采用SP免疫组化分别检测43例SCLC及40例NSCLC患者癌组织Notch-1抗体的表达,分析Notch-1抗体表达缺失与SCLC临床病理特征、淋巴结转移及患者预后的关系.结果 Notch-1抗体在SCLC中的表达率为20.93%( 9/43),而在NSCLC中则高达65.00%( 26/40).Notch-1抗体在SCLC中的表达与临床分期及有无淋巴结转移相关(分别x2=5.42和P<0.05,x2=4.88,P<0.05),但与患者年龄、性别、肿瘤位置、肿瘤大小无关(P均>0.05);与NSCLC比较,Notch-1抗体在SCLC中的表达差异有统计学意义(x2 =16.50,P<0.05).Kaplan-Meier生存分析证实Notch-1抗体阳性患者5年生存率较阴性患者为高(x2=19.87,P<0.05);Cox比例风险回归分析显示Notch-1抗体阳性可明显降低SCLC患者的死亡风险.结论 Notch-1抗体在SCLC与NSCLC中的阳性表达率有明显差异,与SCLC临床分期、淋巴结转移及预后有关.因此,Notch-1表达在SCLC的诊断及预后评估方面具有较好的应用价值. .

关 键 词:肺癌  SCLC  Notch-1  免疫组化  预后

The correlation of notch-1 expression and comprehensive analysis with prognosis in small cell lung cancer
XIAO Wei-hua,MA Hai-fen,LI Jun-qiang,YU Ji-hong,HE Ji,CHEN Guo-rong. The correlation of notch-1 expression and comprehensive analysis with prognosis in small cell lung cancer[J]. Clinical Medicine of China, 2011, 27(10). DOI: 10.3760/cma.j.issn.1008-6315.2011.10.033
Authors:XIAO Wei-hua  MA Hai-fen  LI Jun-qiang  YU Ji-hong  HE Ji  CHEN Guo-rong
Abstract:Objective To investigate the clinical significance of Notch-1 expression in small cell lung cancer(SCLC) and non-small cell lung cancer(NSCLC),and analyze the role of it in prognosis.Methods SP immunohistochemistry was used to detect the expression of Notch-1 antibody in 43 of SCLC and 40 of NSCLC tissues.Further analysis was carried out to interpret the association of Notch-1 antibody expression with clinicopathological features,lymph node metastasis and prognosis in SCLC.Results The positive rate of Notch-1 expression was 20.93% ( 9/43 ) in SCLC,while 65.00% ( 26/40 ) in NSCLC.The expression of Notch-1 antibody was associated with clinical stage and lymph node metastasis ( x2 =5.42,P < 0.05 ; x2 =4.88,P < 0.05respectively),but was not associated with age,sex,tumor location,tumor size ( Ps > 0.05 ).Compared with NSCLC,the expression rates of Notch-1 antibody were significantly higher in SCLC ( x2 =16.50,P < 0.05 ).Kaplan-Meier survival analysis indicated that the survival time of patients with positive Notch-1 expression was significantly longer than that of patients with negative staining( x2 =19.87,P < 0.05 ).Cox regression analysis showed that Notch-1 antibody could significantly reduce the risk of death in patients with SCLC.Conclusion The positive expressions of Notch-1 were significantly different in SCLC and NSCLC,which linked to the clinicalstage,lymph node metastasis and poor prognosis.Accordingly,the expression of Notch-1 may have good value in diagnosis and prognosis.
Keywords:Lung cancer  small cell lung cancer  Notch-1  Immunohistochemistry  Prognosis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号